Global Needle Free Blood Drawing Devices Market – Industry Trends and Forecast to 2028

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Global Needle Free Blood Drawing Devices Market – Industry Trends and Forecast to 2028

  • Medical Devices
  • Jan 2021
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Circumvent the Tariff challenges with an agile supply chain Consulting

Supply Chain Ecosystem Analysis now part of DBMR Reports

Global Needle Free Blood Drawing Devices Market

Market Size in USD Million

CAGR :  % Diagram

Bar chart comparing the Global Needle Free Blood Drawing Devices Market size in 2020 - 359.63 and 2028 - 553.59, highlighting the projected market growth. USD 359.63 Million USD 553.59 Million 2020 2028
Diagram Forecast Period
2021 –2028
Diagram Market Size (Base Year)
USD 359.63 Million
Diagram Market Size (Forecast Year)
USD 553.59 Million
Diagram CAGR
%
Diagram Major Markets Players
  • Velano VascularInc.
  • Siemens
  • Romsons
  • TassoInc.
  • Seventh Sense Biosystems

Global Needle Free Blood Drawing Devices Market, By Product Type (Handheld Devices Wearable Devices), Technology Type (Venepunture, Touch Based), End Users (Hospitals, Research Organizations, Diagnostic Centers, Personal Clinics, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028

Needle Free Blood Drawing Devices Market Market Analysis and Insights : Global Needle Free Blood Drawing Devices Market 

Needle free blood drawing devices market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 1,347.44 million by 2028 and is expected to grow at a CAGR of 4.96% in the above mentioned forecast period.

Needle-free blood drawing devices are made as a comparatively pain-free alternative to conventionally used devices. The needle-free blood drawing device operates by providing a micro-particle with momentum, which then infiltrates the adjacent dermal tissue.

The high demand as well as increase in blood draws across the world is amongst the important factors intensifying the growth and demand of needle free blood drawing devices market. In addition, the rising prevalence of fatalities that can be avoided by early detection and treatment, particularly in emerging economies is also contributing to the growth in the global market over the forecast period of 2021 to 2028. Also the high demand for blood donations and blood components along with increasing number of accidents and trauma cases are also enhancing the growth of the market. Likewise, the increasing disease incidence as well as the regulatory standards and safety policies are also likely to influence the demand of needle free blood drawing devices therefore lifting the market growth in the above mentioned forecast period. The rapid increase in health awareness amongst consumers has resulted rising number of protective and periodic health checkup, counting blood tests will further accelerate the expansion of the needle free blood drawing devices market and are also are offering significant growth opportunities for the market in the forecast period of 2021 to 2028.

However, the high economic expenditure and unexplored will curb the growth of the needle free blood drawing devices market, whereas the high cost coupled with the process of blood drawing using needle-free blood drawing device is comparatively when to compared with traditional blood drawing have the potential to challenge the growth of the needle free blood drawing devices market.

This needle free blood drawing devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on needle free blood drawing devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Needle Free Blood Drawing Devices Market Scope and Market Size

Needle free blood drawing devices market is segmented on the basis of product type, technology and end users. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of product type, the needle free blood drawing devices market is segmented into handheld devices and wearable devices.
  • On the basis of technology type, the needle free blood drawing devices market is segmented into venepunture and touch based.
  • The end users segment of needle free blood drawing devices market is segmented into hospitals, research organizations, diagnostic centers, personal clinics and others.

Needle Free Blood Drawing Devices Market Country Level Analysis

Needle free blood drawing devices market is analyzed and market size insights and trends are provided by country, product type, technology and end user as referenced above.

The countries covered in the  needle free blood drawing devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.

North America region leads the needle free blood drawing devices market owing to rapid increase in the adoption rate of devices in many health care centers within the region. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of increasing disposable income and increasing prevalence of sepsis and HAI this particular region.

The country section of the needle free blood drawing devices market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Needle free blood drawing devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for needle free blood drawing devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the needle free blood drawing devices market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Needle Free Blood Drawing Devices Market Share Analysis

Needle free blood drawing devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to needle free blood drawing devices market.

The major players covered in the needle free blood drawing devices market report are Velano Vascular, Inc., Siemens, Romsons, Tasso, Inc., Seventh Sense Biosystems, Novartis AG, AlphaBiolabs Ltd, and Polymedicure, among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF GLOBAL NEEDLE FREE BLOOD DRAWING DEVICES MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATION

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 KEY TAKEAWAYS

2.2 ARRIVING AT THE GLOBAL NEEDLE FREE BLOOD DRAWING DEVICES MARKET SIZE

2.2.1 VENDOR POSITIONING GRID

2.2.2 TECHNOLOGY LIFE LINE CURVE

2.2.3 TRIPOD DATA VALIDATION MODEL

2.2.4 MARKET GUIDE

2.2.5 MULTIVARIATE MODELLING

2.2.6 TOP TO BOTTOM ANALYSIS

2.2.7 CHALLENGE MATRIX

2.2.8 APPLICATION COVERAGE GRID

2.2.9 STANDARDS OF MEASUREMENT

2.2.10 VENDOR SHARE ANALYSIS

2.2.11 SALES VOLUME DATA

2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS

2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES

2.3 GLOBAL NEEDLE FREE BLOOD DRAWING DEVICES MARKET: RESEARCH SNAPSHOT

2.4 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 CHALLENGES

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 REGULATORY SCENARIO

7 INDUSTRY INSIGHTS

8 IMPACT OF COVID-19 PANDEMIC ON THE MARKET

8.1 PRICE IMPACT

8.2 IMPACT ON DEMAND

8.3 IMPACT ON SUPPLY CHAIN

8.4 STRATEGIC DECISION FOR MANUFACTURERS

8.5 CONCLUSION

9 GLOBAL NEEDLE FREE BLOOD DRAWING DEVICES MARKET, BY PRODUCT

9.1 OVERVIEW

9.2 HANDHELD DEVICES

9.2.1 PEDIATRIC

9.2.2 ADULT BASED

9.3 WEARABLE DEVICES

9.3.1 PEDIATRIC

9.3.2 ADULT BASED

10 GLOBAL NEEDLE FREE BLOOD DRAWING DEVICES MARKET, BY ERGONOMICS

10.1 OVERVIEW

10.2 VENEPUNTURE

10.3 TOUCH BASED

11 GLOBAL NEEDLE FREE BLOOD DRAWING DEVICES MARKET, BY MODALITY

11.1 OVERVIEW

11.2 DIGITAL

11.3 OPTICAL

12 GLOBAL NEEDLE FREE BLOOD DRAWING DEVICES MARKET, BY APPLICATION

12.1 OVERVIEW

12.2 DIAGNOSTIC

12.2.1 INFECTIOUS DISEASES

12.2.1.1. Handheld Devices

12.2.1.2. Wearable Devices

12.2.2 NON-INFECTIOUS DISEASES

12.2.2.1. Handheld Devices

12.2.2.2. Wearable Devices

12.2.3 OTHERS

12.3 TREATMENT

12.3.1 HANDHELD DEVICES

12.3.2 WEARABLE DEVICES

13 GLOBAL NEEDLE FREE BLOOD DRAWING DEVICES MARKET, BY END USER

13.1 OVERVIEW

13.2 HOSPITALS

13.3 RESEARCH ORGANIZATIONS

13.4 DIAGNOSTIC CENTERS

13.5 PERSONAL CLINICS

13.6 OTHERS

14 GLOBAL NEEDLE FREE BLOOD DRAWING DEVICES MARKET, BY DISTRIBUTION CHANNEL

14.1 OVERVIEW

14.2 DIRECT TENDERS

14.3 RETAIL SALES

15 GLOBAL NEEDLE FREE BLOOD DRAWING DEVICES MARKET, COMPANY LANDSCAPE

15.1 COMPANY SHARE ANALYSIS: GLOBAL

15.2 COMPANY SHARE ANALYSIS: NORTH AMERICA

15.3 COMPANY SHARE ANALYSIS: EUROPE

15.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

15.5 MERGERS & ACQUISITIONS

15.6 NEW PRODUCT DEVELOPMENT & APPROVALS

15.7 EXPANSIONS

15.8 REGULATORY CHANGES

15.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

16 GLOBAL NEEDLE FREE BLOOD DRAWING DEVICES MARKET, BY REGION

16.1 GLOBAL NEEDLE FREE BLOOD DRAWING DEVICES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

16.2 NORTH AMERICA

16.2.1 U.S.

16.2.2 CANADA

16.2.3 MEXICO

16.3 GLOBAL

16.3.1 GERMANY

16.3.2 FRANCE

16.3.3 U.K.

16.3.4 HUNGARY

16.3.5 LITHUANIA

16.3.6 AUSTRIA

16.3.7 IRELAND

16.3.8 NORWAY

16.3.9 POLAND

16.3.10 ITALY

16.3.11 SPAIN

16.3.12 RUSSIA

16.3.13 TURKEY

16.3.14 NETHERLANDS

16.3.15 SWITZERLAND

16.3.16 LUXEMBOURG

16.3.17 REST OF GLOBAL

16.4 ASIA-PACIFIC

16.4.1 JAPAN

16.4.2 CHINA

16.4.3 SOUTH KOREA

16.4.4 INDIA

16.4.5 AUSTRALIA

16.4.6 SINGAPORE

16.4.7 THAILAND

16.4.8 MALAYSIA

16.4.9 INDONESIA

16.4.10 PHILIPPINES

16.4.11 VIETNAM

16.4.12 REST OF ASIA-PACIFIC

16.5 SOUTH AMERICA

16.5.1 BRAZIL

16.5.2 ARGENTINA

16.5.3 PERU

16.5.4 REST OF SOUTH AMERICA

16.6 MIDDLE EAST AND AFRICA

16.6.1 SOUTH AFRICA

16.6.2 SAUDI ARABIA

16.6.3 UAE

16.6.4 EGYPT

16.6.5 KUWAIT

16.6.6 ISRAEL

16.6.7 REST OF MIDDLE EAST AND AFRICA

16.7 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

17 GLOBAL NEEDLE FREE BLOOD DRAWING DEVICES MARKET, SWOT AND DBMR ANALYSIS

18 GLOBAL NEEDLE FREE BLOOD DRAWING DEVICES MARKET, COMPANY PROFILE

18.1 VELANO VASCULAR, INC.

18.1.1 COMPANY OVERVIEW

18.1.2 REVENUE ANALYSIS

18.1.3 GEOGRAPHIC PRESENCE

18.1.4 PRODUCT PORTFOLIO

18.1.5 RECENT DEVELOPMENTS

18.2 SIEMENS

18.2.1 COMPANY OVERVIEW

18.2.2 REVENUE ANALYSIS

18.2.3 GEOGRAPHIC PRESENCE

18.2.4 PRODUCT PORTFOLIO

18.2.5 RECENT DEVELOPMENTS

18.3 ROMSONS

18.3.1 COMPANY OVERVIEW

18.3.2 REVENUE ANALYSIS

18.3.3 GEOGRAPHIC PRESENCE

18.3.4 PRODUCT PORTFOLIO

18.3.5 RECENT DEVELOPMENTS

18.4 TASSO, INC.

18.4.1 COMPANY OVERVIEW

18.4.2 REVENUE ANALYSIS

18.4.3 GEOGRAPHIC PRESENCE

18.4.4 PRODUCT PORTFOLIO

18.4.5 RECENT DEVELOPMENTS

18.5 SEVENTH SENSE BIOSYSTEMS

18.5.1 COMPANY OVERVIEW

18.5.2 REVENUE ANALYSIS

18.5.3 GEOGRAPHIC PRESENCE

18.5.4 PRODUCT PORTFOLIO

18.5.5 RECENT DEVELOPMENTS

18.6 NOVARTIS AG

18.6.1 COMPANY OVERVIEW

18.6.2 REVENUE ANALYSIS

18.6.3 GEOGRAPHIC PRESENCE

18.6.4 PRODUCT PORTFOLIO

18.6.5 RECENT DEVELOPMENTS

18.7 ALPHABIOLABS LTD

18.7.1 COMPANY OVERVIEW

18.7.2 REVENUE ANALYSIS

18.7.3 GEOGRAPHIC PRESENCE

18.7.4 PRODUCT PORTFOLIO

18.7.5 RECENT DEVELOPMENTS

18.8 POLYMEDICURE

18.8.1 COMPANY OVERVIEW

18.8.2 REVENUE ANALYSIS

18.8.3 GEOGRAPHIC PRESENCE

18.8.4 PRODUCT PORTFOLIO

18.8.5 RECENT DEVELOPMENTS

18.9 ARDINAL HEALTH

18.9.1 COMPANY OVERVIEW

18.9.2 REVENUE ANALYSIS

18.9.3 GEOGRAPHIC PRESENCE

18.9.4 PRODUCT PORTFOLIO

18.9.5 RECENT DEVELOPMENTS

18.1 VASCULOGIC

18.10.1 COMPANY OVERVIEW

18.10.2 REVENUE ANALYSIS

18.10.3 GEOGRAPHIC PRESENCE

18.10.4 PRODUCT PORTFOLIO

18.10.5 RECENT DEVELOPMENTS

18.11 RUTGERS UNIVERSITY–NEW BRUNSWICK

18.11.1 COMPANY OVERVIEW

18.11.2 REVENUE ANALYSIS

18.11.3 GEOGRAPHIC PRESENCE

18.11.4 PRODUCT PORTFOLIO

18.11.5 RECENT DEVELOPMENTS

18.12 HANGZHOU ROLLMED CO., LTD.

18.12.1 COMPANY OVERVIEW

18.12.2 REVENUE ANALYSIS

18.12.3 GEOGRAPHIC PRESENCE

18.12.4 PRODUCT PORTFOLIO

18.12.5 RECENT DEVELOPMENTS

18.13 CERBA HEALTHCARE S.A.S.

18.13.1 COMPANY OVERVIEW

18.13.2 REVENUE ANALYSIS

18.13.3 GEOGRAPHIC PRESENCE

18.13.4 PRODUCT PORTFOLIO

18.13.5 RECENT DEVELOPMENTS

*NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST

19 RELATED REPORTS

20 CONCLUSION

21 QUESTIONNAIRE

22 ABOUT DATA BRIDGE MARKET RESEARCH

View Detailed Information Right Arrow

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The market is segmented based on , By Product Type (Handheld Devices Wearable Devices), Technology Type (Venepunture, Touch Based), End Users (Hospitals, Research Organizations, Diagnostic Centers, Personal Clinics, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028 .
The Global Needle Free Blood Drawing Devices Market size was valued at USD 359.63 USD Million in 2020.
The Global Needle Free Blood Drawing Devices Market is projected to grow at a CAGR of 9.9% during the forecast period of 2021 to 2028.
The major players operating in the market include Velano VascularInc., Siemens, Romsons, TassoInc., Seventh Sense Biosystems, Novartis AG, AlphaBiolabs Ltd, and Polymedicure.

Industry Related Reports

Testimonial